HOME Top Market Reports In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology) - Forecast to 2023

In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology) - Forecast to 2023

By: marketsandmarkets.com
Publishing Date: March 2018
Report Code: MD 3609

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global in vitro diagnostics market was valued at USD 64.02 Billion in 2017 and is projected to reach USD 87.93 Billion by 2023, at a CAGR of 5.2% during the forecast period. The base year considered for the study is 2017 and the forecast period is from 2018 to 2023.

Objectives of the study are:

  • To define, describe, and forecast the global in vitro diagnostics (IVD) market on the basis of product, technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the IVD market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the global IVD market with respect to five main regions (along with countries) - North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To strategically profile the key players in the global IVD market and comprehensively analyze their core competencies and In Vitro Diagnostics market shares
  • To track and analyze competitive developments such as partnerships, agreements, collaborations, acquisitions, expansions, new product/technology developments, and product upgrades in the IVD market

Research Methodology

The study estimates the in vitro diagnostics market size for 2018 and projects its demand till 2023. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the supply side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the market. Primary sources from the demand side include physicians, nurses, pathologists, and laboratory technicians. For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the market. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. This research study involves the extensive usage of secondary sources, directories, and databases includes in Vitro Diagnostics Associations and Journals, European Diagnostic Manufacturers Association, American Association for Clinical Chemistry, Centers for Disease Control and Prevention (CDC), the World Bank etc., in order to identify and collect information useful for this technical, market-oriented, and financial study of the market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.

In Vitro Diagnostics/IVD Market

To know about the assumptions considered for the study, download the pdf brochure

Roche Diagnostics Limited (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific (US) are the leading players in this market. Other players in this market are Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMιrieux (France), DiaSorin (Italy), Ortho Clinical Diagnostics (US), and QIAGEN (Germany). Major players in this market are continuously focusing on securing higher market shares through product launches, expansions, agreements, partnerships, collaborations, and acquisitions.

Target Audience for this Report:

  • IVD Product Manufacturers
  • Group Purchase Organizations (GPOs)
  • OEM Manufacturers
  • Pathologists and Pathology Laboratories
  • Distributors of IVD Products
  • Hospitals and Clinics
  • Healthcare Institutions
  • Research Institutes
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors

Scope of the Report

This report categorizes the global market into the following segments:

Global In Vitro Diagnostics Market, by Product & Service

  • Reagents & Kits
  • Instruments
    • Fully-automated Instruments
    • Semi-automated Instruments
    • Others
  • Data Management Software
  • Services

Global In Vitro Diagnostics Market, by Technology

  • Immunochemistry/Immunoassay
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassay (CLIA)
      • Fluorescence Immunoassay (FIA)
      • Colorimetric Immunoassay (CI)
    • Radioimmunoassays (RIA)
    • Rapid Tests
    • Western Blot
    • ELISPOT
  • Clinical Chemistry
    • Basic Metabolic Panel
    • Electrolyte Panel
    • Liver Panel
    • Lipid Profile
    • Renal Profile
    • Thyroid Function Panel
    • Specialty Chemicals
  • Molecular Diagnostics
    • Polymerase Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridization (In-situ Hybridization & FISH)
    • DNA Sequencing & NGS
    • Microarray
    • Others
  • Microbiology
  • Hematology
  • Coagulation & Hemostasis
  • Urinalysis
  • Others

Global In Vitro Diagnostics Market, by Application

  • Diabetes
  • Infectious Diseases
  • Oncology/Cancer
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing/Pharmacogenomics
  • HIV/AIDS
  • Others  

Global In Vitro Diagnostics Market, by End User

  • Laboratories
    • Large/Reference Laboratories
    • Medium-sized Laboratories
    • Small Laboratories
  • Hospitals
  • Academics
  • Point-Of-Care Testing
  • Patient Self-Testing
  • Others

Global In Vitro Diagnostics Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • Russia
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLA
  • Middle East & Africa
    • Saudi Arabia
    • Rest of Middle East & Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the service portfolio of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific in-vitro diagnostics market in Russia, Taiwan, Australia, New Zealand, and other countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 26)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 30)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
                    2.1.2.3 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 39)

4 Premium Insights (Page No. - 46)
    4.1 In Vitro Diagnostics (IVD) Market Overview
    4.2 Asia Pacific: Market, By Product & Service
    4.3 Geographic Snapshot of the Market
    4.4 Geographic Mix: In Vitro Diagnostics Market
    4.5 Market: Developing vs Developed Markets

5 Market Overview (Page No. - 50)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Geriatric Population and Subsequent Growth in the Prevalence of Chronic and Infectious Diseases
                    5.2.1.2 Increasing Adoption of Fully Automated Instruments and Automation in Laboratories
                    5.2.1.3 Growing Awareness on Personalized Medicine
                    5.2.1.4 Increasing Adoption of Point-Of-Care Testing
           5.2.2 Restraint
                    5.2.2.1 Unfavorable Reimbursement Scenario
           5.2.3 Opportunities
                    5.2.3.1 Development of Condition-Specific Markers and Tests
                    5.2.3.2 Growing Significance of Companion Diagnostics
                    5.2.3.3 Growth Opportunities in Emerging Countries
           5.2.4 Challenges
                    5.2.4.1 Changing Regulatory Landscape
                    5.2.4.2 Operational Barriers Faced in Conducting Diagnostic Tests

6 Industry Insights (Page No. - 60)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Automation of Clinical Laboratory Techniques
           6.2.2 Microfluidics-Based Poc and Loc Diagnostic Devices for Laboratory Testing
           6.2.3 Rise in Number of Reagent Rental Agreements
    6.3 Regulatory Overview
           6.3.1 US
           6.3.2 Canada
           6.3.3 Europe
           6.3.4 Japan
           6.3.5 China
           6.3.6 India
           6.3.7 Indonesia
           6.3.8 Russia
           6.3.9 Saudi Arabia
           6.3.10 Mexico
           6.3.11 Brazil
           6.3.12 South Korea
    6.4 Vendor Benchmarking

7 In Vitro Diagnostics Market, By Product & Service (Page No. - 76)
    7.1 Introduction
    7.2 Reagents & Kits
    7.3 Instruments
           7.3.1 Fully Automated Instruments
           7.3.2 Semi-Automated Instruments
           7.3.3 Other Instruments
    7.4 Data Management Software
    7.5 Services

8 In Vitro Diagnostics Market, By Technology (Page No. - 92)
    8.1 Introduction
    8.2 Immunoassay/Immunochemistry
           8.2.1 Enzyme-Linked Immunosorbent Assay
                    8.2.1.1 Chemiluminescence Immunoassays
                    8.2.1.2 Fluorescence Immunoassays
                    8.2.1.3 Colorimetric Immunoassays
           8.2.2 Radioimmunoassay
           8.2.3 Rapid Test
           8.2.4 Western Blotting
           8.2.5 Enzyme-Linked Immunospot Assays
    8.3 Clinical Chemistry
           8.3.1 Basic Metabolic Panel
           8.3.2 Electrolyte Panel
           8.3.3 Liver Panel
           8.3.4 Lipid Profile
           8.3.5 Renal Profile
           8.3.6 Thyroid Function Panel
           8.3.7 Specialty Chemical Tests
    8.4 Molecular Diagnostics
           8.4.1 Polymerase Chain Reaction
           8.4.2 Isothermal Nucleic Acid Amplification Technology
           8.4.3 Microarray
           8.4.4 Hybridization
           8.4.5 Dna Sequencing & Next-Generation Sequencing
           8.4.6 Other Mdx Technologies
    8.5 Microbiology
    8.6 Hematology
    8.7 Coagulation and Hemostasis
    8.8 Urinalysis
    8.9 Other IVD Technologies

9 In Vitro Diagnostics Market, By Application (Page No. - 153)
    9.1 Introduction
    9.2 Infectious Diseases
    9.3 Diabetes
    9.4 Oncology
    9.5 Cardiology
    9.6 Autoimmune Diseases
    9.7 Nephrology
    9.8 Drug Testing/Pharmacogenomics
    9.9 HIV/Aids
    9.10 Other Applications

10 In Vitro Diagnostics Market, By End User (Page No. - 171)
     10.1 Introduction
     10.2 Hospitals
     10.3 Laboratories
             10.3.1 Large/Reference Laboratories
             10.3.2 Medium-Sized Laboratories
             10.3.3 Small Laboratories
     10.4 Point-Of-Care Testing
     10.5 Patient Self-Testing
     10.6 Academic Institutes
     10.7 Other End Users

11 In Vitro Diagnostics Market, By Region (Page No. - 185)
     11.1 Introduction
     11.2 North America
             11.2.1 US
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 France
             11.3.3 UK
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Russia
             11.3.7 Rest of Europe
     11.4 Asia Pacific
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 South Korea
             11.4.5 Indonesia
             11.4.6 Rest of Asia Pacific
     11.5 Latin America
             11.5.1 Brazil
             11.5.2 Mexico
             11.5.3 Rest of Latin America
     11.6 Middle East & Africa
             11.6.1 Saudi Arabia
             11.6.2 Rest of the Middle East & Africa

12 Competitive Landscape (Page No. - 281)
     12.1 Introduction
     12.2 Market Share Analysis
             12.2.1 Market Share Analysis, By Technology
                        12.2.1.1 Clinical Chemistry
                        12.2.1.2 Immunochemistry/Immunoassay
                        12.2.1.3 Microbiology
                        12.2.1.4 Molecular Diagnostics
                        12.2.1.5 Hematology
                        12.2.1.6 Coagulation
     12.3 Competitive Situation and Trends
             12.3.1 Product Launches
             12.3.2 Agreements, Partnerships, and Collaborations
             12.3.3 Acquisitions
             12.3.4 Expansions
             12.3.5 Other Strategies

13 Company Profiles (Page No. - 294)
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
     13.1 Roche Diagnostics
     13.2 Danaher Corporation
     13.3 Abbott Laboratories, Inc.
     13.4 Siemens AG
     13.5 Sysmex Corporation
     13.6 Thermo Fisher Scientific
     13.7 Becton, Dickinson and Company
     13.8 Biomιrieux Sa
     13.9 Bio-Rad Laboratories, Inc.
     13.10 Johnson & Johnson
     13.11 Agilent Technologies
     13.12 Qiagen
     13.13 Diasorin
     13.14 Ortho Clinical Diagnostics (A Part of Carlyle Group)

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 393)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.4 Ntroducing RT: Real-Time Market Intelligence
     14.5 Available Customizations
     14.6 Related Reports
     14.7 Author Details


List of Tables (283 Tables)

Table 1 Global IVD Market Snapshot
Table 2 Number of People With Diabetes, By Region, 2015 vs 2040 (Million Individuals)
Table 3 Fully Automated Systems Launched By Key Players
Table 4 New Tests Launched By Key Players
Table 5 US: Classification of In Vitro Diagnostic Devices
Table 6 US: Time, Cost, and Complexity of Registration Process
Table 7 Canada: Time, Cost, and Complexity of Registration Process
Table 8 Europe: Classification of IVD Devices
Table 9 Europe: Time, Cost, and Complexity of Registration Process
Table 10 Japan: Classification of IVD Reagents
Table 11 Japan: Time, Cost, and Complexity of Registration Process
Table 12 China: Time, Cost, and Complexity of Registration Process
Table 13 India: Time, Cost, and Complexity of Registration Process
Table 14 Indonesia: Registration Process for IVD Devices
Table 15 Russia: Classification of IVD Devices
Table 16 Saudi Arabia: Time, Cost, and Complexity of Registration Process
Table 17 Mexico: Time, Cost, and Complexity of Registration Process
Table 18 Brazil: Time, Cost, and Complexity of Registration Process
Table 19 South Korea: Time, Cost, and Complexity of Registration Process
Table 20 In Vitro Diagnostic Products & Services Market: Product Portfolio Analysis
Table 21 IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 22 In Vitro Diagnostic Reagents & Kits Market, By Country, 2016–2023 (USD Million)
Table 23 In Vitro Diagnostic Reagents & Kits Market, By Technology, 2016–2023 (USD Million)
Table 24 In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 25 In Vitro Diagnostic Instruments Market, By Country, 2016–2023 (USD Million)
Table 26 In Vitro Diagnostic Instruments Market, By Technology, 2016–2023 (USD Million)
Table 27 Major Lab Automation Systems & Fully Automated Instruments in the Market
Table 28 Fully Automated IVD Instruments Market, By Country, 2016–2023 (USD Million)
Table 29 Semi-Automated IVD Instruments Market, By Country, 2016–2023 (USD Million)
Table 30 Other IVD Instruments Market, By Country, 2016–2023 (USD Million)
Table 31 Key Data Management Software Solutions Available in the Market
Table 32 In Vitro Diagnostic Data Management Software Market, By Country, 2016–2023 (USD Million)
Table 33 In Vitro Diagnostic Data Management Software Market, By Technology, 2016–2023 (USD Million)
Table 34 In Vitro Diagnostic Services Market, By Country, 2016–2023 (USD Million)
Table 35 In Vitro Diagnostic Services Market, By Technology, 2016–2023 (USD Million)
Table 36 In Vitro Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 37 Immunoassay/Immunochemistry Analyzers Available in the Market
Table 38 Immunoassay/Immunochemistry Market, By Type, 2016–2023 (USD Million)
Table 39 Immunoassay/Immunochemistry Market, By Country, 2016–2023 (USD Million)
Table 40 Elisa Analyzers Available in the Market
Table 41 Enzyme-Linked Immunosorbent Assay Market, By Country, 2016–2023 (USD Million)
Table 42 Enzyme-Linked Immunosorbent Assay Market, By Type, 2016–2023 (USD Million)
Table 43 Chemiluminescence Immunoassay Systems Available in the Market
Table 44 Chemiluminescence Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 45 Fluorescence Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 46 Colorimetric Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 47 Radioimmunoassay Market, By Country, 2016–2023 (USD Million)
Table 48 Rapid Tests Available in the Market
Table 49 Rapid Test Market, By Country, 2016–2023 (USD Million)
Table 50 Western Blotting Systems Available in the Market
Table 51 Western Blotting Market, By Country, 2016–2023 (USD Million)
Table 52 Elispot Assays Market, By Country, 2016–2023 (USD Million)
Table 53 Clinical Chemistry Analyzers for High- and Mid-Volume Laboratories
Table 54 Clinical Chemistry Analyzers for Low-Volume Laboratories
Table 55 Blood Gas Analyzers Available in the Market
Table 56 Clinical Chemistry Market, By Country, 2016–2023 (USD Million)
Table 57 Clinical Chemistry Market, By Test Type, 2016–2023 (USD Million)
Table 58 Basic Metabolic Panel Market, By Country, 2016–2023 (USD Million)
Table 59 Electrolyte Panel Market, By Country, 2016–2023 (USD Million)
Table 60 Liver Panel Market, By Country, 2016–2023 (USD Million)
Table 61 Lipid Profile Market, By Country, 2016–2023 (USD Million)
Table 62 Renal Profile Market, By Country, 2016–2023 (USD Million)
Table 63 Thyroid Function Panel Market, By Country, 2016–2023 (USD Million)
Table 64 Specialty Chemical Tests Market, By Country, 2016–2023 (USD Million)
Table 65 Automated Molecular Platforms, By Key Market Player
Table 66 Molecular Diagnostics Market, By Country, 2016–2023 (USD Million)
Table 67 Molecular Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 68 PCR Instruments, By Key Market Player
Table 69 PCR Market, By Country, 2016–2023 (USD Million)
Table 70 Isothermal Nucleic Acid Amplification Technology Market, By Country, 2016–2023 (USD Million)
Table 71 Microarray Market, By Country, 2016–2023 (USD Million)
Table 72 Hybridization Market, By Country, 2016–2023 (USD Million)
Table 73 Ngs Instruments, By Key Market Player
Table 74 Dna Sequencing & Ngs Market, By Country, 2016–2023 (USD Million)
Table 75 Other Molecular Diagnostic Technologies Market, By Country, 2016–2023 (USD Million)
Table 76 Microbiology Instruments, By Key Market Player
Table 77 Microbiology Market, By Country, 2016–2023 (USD Million)
Table 78 Hematology Analyzers, By Key Market Player
Table 79 Hematology Market, By Country, 2016–2023 (USD Million)
Table 80 Coagulation Analyzers, By Key Market Player
Table 81 Point of Care/Self-Monitoring Coagulation Analyzers, By Key Market Player
Table 82 Coagulation & Hemostasis Market, By Country, 2016–2023 (USD Million)
Table 83 Urinalysis Instruments, By Key Market Player
Table 84 Urinalysis Market, By Country, 2016–2023 (USD Million)
Table 85 Blood Glucose Testing Systems, By Key Market Player
Table 86 Tissue Processors, Embedders, Microtomes, and Stainers Offered By Key Market Players
Table 87 Other IVD Technologies Market, By Country, 2016–2023 (USD Million)
Table 88 In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 89 IVD Market for Infectious Diseases, By Country, 2016–2023 (USD Million)
Table 90 Global Diabetic Patient Population in 2015 and 2040 (Million)
Table 91 In Vitro Diagnostic Market for Diabetes, By Country, 2016–2023 (USD Million)
Table 92 In Vitro Diagnostic Market for Oncology, By Country, 2016–2023 (USD Million)
Table 93 In Vitro Diagnostics Market for Cardiology, By Country, 2016–2023 (USD Million)
Table 94 In Vitro Diagnostic Market for Autoimmune Diseases, By Country, 2016–2023 (USD Million)
Table 95 In Vitro Diagnostics Market for Nephrology, By Country, 2016–2023 (USD Million)
Table 96 In Vitro Diagnostic Market for Drug Testing/Pharmacogenomics, By Country, 2016–2023 (USD Million)
Table 97 IVD Market for HIV/Aids, By Country, 2016–2023 (USD Million)
Table 98 In Vitro Diagnostics Market for Other Applications, By Country, 2016–2023 (USD Million)
Table 99 In Vitro Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 100 IVD Market for Hospitals, By Country, 2016–2023 (USD Million)
Table 101 In Vitro Diagnostic Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 102 In Vitro Diagnostics Market for Laboratories, By Country, 2016–2023 (USD Million)
Table 103 Large/Reference Laboratories Market, By Country, 2016–2023 (USD Million)
Table 104 Medium-Sized Laboratories Market, By Country, 2016–2023 (USD Million)
Table 105 Small Laboratories Market, By Country, 2016–2023 (USD Million)
Table 106 In Vitro Diagnostics Market for Poc Testing, By Country, 2016–2023 (USD Million)
Table 107 IVD Market for Patient Self-Testing, By Country, 2016–2023 (USD Million)
Table 108 In Vitro Diagnostic Market for Academic Institutes, By Country, 2016–2023 (USD Million)
Table 109 In Vitro Diagnostic In Vitro Diagnostics Market for Other End Users, By Country, 2016–2023 (USD Million)
Table 110 In Vitro Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 111 North America: In Vitro Diagnostics Market, By Country, 2016–2023 (USD Million)
Table 112 North America: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 113 North America: Instruments Market, By Type, 2016–2023 (USD Million)
Table 114 North America: Market, By Technology, 2016–2023 (USD Million)
Table 115 North America: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 116 North America: IVD Market, By End User, 2016–2023 (USD Million)
Table 117 North America: Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 118 US: Key Macroindicators
Table 119 US: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 120 US: Instruments Market, By Type, 2016–2023 (USD Million)
Table 121 US: In Vitro Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 122 US: IVD Market, By Application, 2016–2023 (USD Million)
Table 123 US: IVD Market, By End User, 2016–2023 (USD Million)
Table 124 US: In Vitro Diagnostics Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 125 Canada: Key Macroindicators
Table 126 Canada: In Vitro Diagnostic Market, By Product & Service, 2016–2023 (USD Million)
Table 127 Canada: IVD Instruments Market, By Type, 2016–2023 (USD Million)
Table 128 Canada: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 129 Canada: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 130 Canada: IVD Market, By End User, 2016–2023 (USD Million)
Table 131 Canada: In Vitro Diagnostic Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 132 Europe: In Vitro Diagnostics Market, By Country/Region, 2016–2023 (USD Million)
Table 133 Europe: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 134 Europe: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 135 Europe: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 136 Europe: IVD Market, By Application, 2016–2023 (USD Million)
Table 137 Europe: In Vitro Diagnostic Market, By End User, 2016–2023 (USD Million)
Table 138 Europe: In Vitro Diagnostics Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 139 Germany: Key Macroindicators
Table 140 Germany: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 141 Germany: Instruments Market, By Type, 2016–2023 (USD Million)
Table 142 Germany: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 143 Germany: IVD Market, By Application, 2016–2023 (USD Million)
Table 144 Germany: IVD Market, By End User, 2016–2023 (USD Million)
Table 145 Germany: In Vitro Diagnostics Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 146 France: Key Macroindicators
Table 147 France: Market, By Product & Service, 2016–2023 (USD Million)
Table 148 France: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 149 France: IVD Market, By Technology, 2016–2023 (USD Million)
Table 150 France: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 151 France: Market, By End User, 2016–2023 (USD Million)
Table 152 France: IVD Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 153 UK: Key Macroindicators
Table 154 UK: In Vitro Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 155 UK: Instruments Market, By Type, 2016–2023 (USD Million)
Table 156 UK: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 157 UK: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 158 UK: Market, By End User, 2016–2023 (USD Million)
Table 159 UK: In Vitro Diagnostic Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 160 Italy: Key Macroindicators
Table 161 Italy: In Vitro Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 162 Italy: Instruments Market, By Type, 2016–2023 (USD Million)
Table 163 Italy: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 164 Italy: IVD Market, By Application, 2016–2023 (USD Million)
Table 165 Italy: In Vitro Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 166 Italy: IVD Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 167 Spain: Key Macroindicators
Table 168 Spain: In Vitro Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 169 Spain: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 170 Spain: IVD Market, By Technology, 2016–2023 (USD Million)
Table 171 Spain: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 172 Spain: IVD Market, By End User, 2016–2023 (USD Million)
Table 173 Spain: In Vitro Diagnostics Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 174 Russia: Key Macroindicators
Table 175 Russia: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 176 Russia: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 177 Russia: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 178 Russia: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 179 Russia: In Vitro Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 180 Russia: In Vitro Diagnostic Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 181 RoE: In Vitro Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 182 RoE: Instruments Market, By Type, 2016–2023 (USD Million)
Table 183 RoE: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 184 RoE: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 185 RoE: IVD Market, By End User, 2016–2023 (USD Million)
Table 186 RoE: In Vitro Diagnostics Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 187 Asia Pacific: Market, By Country/Region, 2016–2023 (USD Million)
Table 188 Asia Pacific: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 189 Asia Pacific: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 190 Asia Pacific: IVD Market, By Technology, 2016–2023 (USD Million)
Table 191 Asia Pacific: IVD Market, By Application, 2016–2023 (USD Million)
Table 192 Asia Pacific: In Vitro Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 193 Asia Pacific: In Vitro Diagnostic Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 194 Japan: Key Macroindicators
Table 195 Japan: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 196 Japan: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 197 Japan: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 198 Japan: In Vitro Diagnostic Market, By Application, 2016–2023 (USD Million)
Table 199 Japan: IVD Market, By End User, 2016–2023 (USD Million)
Table 200 Japan: In Vitro Diagnostics Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 201 China: Key Macroindicators
Table 202 China: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 203 China: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 204 China: IVD Market, By Technology, 2016–2023 (USD Million)
Table 205 China: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 206 China: IVD Market, By End User, 2016–2023 (USD Million)
Table 207 China: In Vitro Diagnostics Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 208 India: Key Macroindicators
Table 209 India: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 210 India: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 211 India: In Vitro Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 212 India: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 213 India: In Vitro Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 214 India: IVD Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 215 South Korea: Market, By Product & Service, 2016–2023 (USD Million)
Table 216 South Korea: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 217 South Korea: Market, By Technology, 2016–2023 (USD Million)
Table 218 South Korea: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 219 South Korea: IVD Market, By End User, 2016–2023 (USD Million)
Table 220 South Korea: In Vitro Diagnostic Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 221 Indonesia: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 222 Indonesia: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 223 Indonesia: Market, By Technology, 2016–2023 (USD Million)
Table 224 Indonesia: IVD Market, By Application, 2016–2023 (USD Million)
Table 225 Indonesia: IVD Market, By End User, 2016–2023 (USD Million)
Table 226 Indonesia: IVD Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 227 RoAPAC: In Vitro Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 228 RoAPAC: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 229 RoAPAC: Market, By Technology, 2016–2023 (USD Million)
Table 230 RoAPAC: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 231 RoAPAC: Market, By End User, 2016–2023 (USD Million)
Table 232 RoAPAC: Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 233 Latin America: In Vitro Diagnostics Market, By Country, 2016–2023 (USD Million)
Table 234 Latin America: IVD Market, By Product & Service, 2016–2023 (USD Million)
Table 235 Latin America: IVD Instruments Market, By Type, 2016–2023 (USD Million)
Table 236 Latin America: In Vitro Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 237 Latin America: Market, By Application, 2016–2023 (USD Million)
Table 238 Latin America: In Vitro Diagnostic Market, By End User, 2016–2023 (USD Million)
Table 239 Latin America: In Vitro Diagnostics Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 240 Brazil: Key Macroindicators
Table 241 Brazil: Market, By Product & Service, 2016–2023 (USD Million)
Table 242 Brazil: IVD Instruments Market, By Type, 2016–2023 (USD Million)
Table 243 Brazil: IVD Market, By Technology, 2016–2023 (USD Million)
Table 244 Brazil: IVD Market, By Application, 2016–2023 (USD Million)
Table 245 Brazil: In Vitro Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 246 Brazil: Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 247 Mexico: Key Macroindicators
Table 248 Mexico: Market, By Product & Service, 2016–2023 (USD Million)
Table 249 Mexico: In Vitro Diagnostic Instruments Market, By Type, 2016–2023 (USD Million)
Table 250 Mexico: Market, By Technology, 2016–2023 (USD Million)
Table 251 Mexico: Market, By Application, 2016–2023 (USD Million)
Table 252 Mexico: IVD Market, By End User, 2016–2023 (USD Million)
Table 253 Mexico: IVD Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 254 RoLA: In Vitro Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 255 RoLA: Instruments Market, By Type, 2016–2023 (USD Million)
Table 256 RoLA: Market, By Technology, 2016–2023 (USD Million)
Table 257 RoLA: Market, By Application, 2016–2023 (USD Million)
Table 258 RoLA: IVD Market, By End User, 2016–2023 (USD Million)
Table 259 RoLA: In Vitro Diagnostic Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 260 Middle East and Africa: Market, By Country, 2016–2023 (USD Million)
Table 261 Middle East and Africa: In Vitro Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 262 Middle East and Africa: IVD Instruments Market, By Type, 2016–2023 (USD Million)
Table 263 Middle East and Africa: In Vitro Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 264 Middle East and Africa: Market, By Application, 2016–2023 (USD Million)
Table 265 Middle East and Africa: Market, By End User, 2016–2023 (USD Million)
Table 266 Middle East and Africa: Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 267 Saudi Arabia: Market, By Product & Service, 2016–2023 (USD Million)
Table 268 Saudi Arabia: IVD Instruments Market, By Type, 2016–2023 (USD Million)
Table 269 Saudi Arabia: In Vitro Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 270 Saudi Arabia: In Vitro Diagnostics Market, By Application, 2016–2023 (USD Million)
Table 271 Saudi Arabia: In Vitro Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 272 Saudi Arabia: IVD Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 273 Rest of Middle East and Africa: In Vitro Diagnostics Market, By Product & Service, 2016–2023 (USD Million)
Table 274 Rest of Middle East and Africa: IVD Instruments Market, By Type, 2016–2023 (USD Million)
Table 275 Rest of Middle East and Africa: In Vitro Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 276 Rest of Middle East and Africa: In Vitro Diagnostic Market, By Application, 2016–2023 (USD Million)
Table 277 Rest of Middle East and Africa: In Vitro Diagnostic Market, By End User, 2016–2023 (USD Million)
Table 278 Rest of Middle East and Africa: IVD Market for Laboratories, By Size, 2016–2023 (USD Million)
Table 279 Product Launches, 2014–2018
Table 280 Agreements, Partnerships, and Collaborations, 2014–2017
Table 281 Acquisitions, 2014–2017
Table 282 Expansions, 2015–2017
Table 283 Other Strategies, 2014–2017


List of Figures (63 Figures)

Figure 1 In Vitro Diagnostics Market Segmentation
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 IVD Market, By Product & Service, 2018 vs 2023 (USD Billion)
Figure 7 IVD Market, By Application, 2018 vs 2023 (USD Billion)
Figure 8 IVD Market, By Technology, 2018 vs 2023 (USD Billion)
Figure 9 Immunochemistry/ Immunoassay Market, By Type, 2018 vs 2023 (USD Billion)
Figure 10 Clinical Chemistry Market, By Type, 2018 vs 2023 (USD Billion)
Figure 11 Molecular Diagnostics Market, By Type, 2018 vs 2023 (USD Billion)
Figure 12 IVD Market, By End User, 2018 vs 2023 (USD Billion)
Figure 13 Geographic Snapshot of the In Vitro Diagnostics Market
Figure 14 Rising Incidence of Chronic Lifestyle Diseases is Driving the Growth of the IVD Market
Figure 15 Reagents & Kits Commanded the Largest Share in 2017
Figure 16 The US Accounted for the Largest Share of the IVD Market in 2017
Figure 17 APAC to Grow at the Highest CAGR in the Forecast Period
Figure 18 Developing Markets to Register A Higher Growth During the Forecast Period
Figure 19 In Vitro Diagnostics Market: Drivers, Restraints, Opportunities, & Challenges
Figure 20 Increase in Geriatric Population, By Country (2011–2030)
Figure 21 Increase in Gross Expenditure on R&D in Emerging Countries, 2012–2014
Figure 22 US: Regulatory Process for IVD Devices
Figure 23 Canada: Regulatory Process for IVD Devices in Canada
Figure 24 Europe: Regulatory Process for IVD Devices
Figure 25 Regulatory Process for IVD Devices in Japan
Figure 26 India: Regulatory Process for IVD Devices
Figure 27 Mexico: Regulatory Process for IVD Devices
Figure 28 Brazil: Regulatory Process for IVD Devices
Figure 29 Reagents & Kits Segment to Witness the Highest Growth Rate During the Forecast Period
Figure 30 Molecular Diagnostics Segment to Register the Highest CAGR During the Forecast Period (2018–2023)
Figure 31 Rapid Tests Segment to Register the Highest Growth Rate During the Forecast Period (2018–2023)
Figure 32 Oncology, the Fastest-Growing Application Segment of the IVD Market
Figure 33 Number of People Living With HIV Globally, 2010–2015
Figure 34 In Vitro Diagnostics Market, By End User, 2018 vs 2023 (USD Million)
Figure 35 Number of Hospitals, By Country/Region (2015)
Figure 36 Number of Laboratories, By Country/Region (2015)
Figure 37 Healthcare Expenditure Across Major Countries, 2000 vs 2014
Figure 38 North America to Account for the Largest Share of the IVD Market in 2023
Figure 39 Geographical Snapshot of the Global IVD Market
Figure 40 North America: In Vitro Diagnostics Market Snapshot
Figure 41 Europe: IVD Market Snapshot
Figure 42 Asia Pacific: IVD Market Snapshot
Figure 43 Key Developments in the In Vitro Diagnostic Market From 2014 to 2018
Figure 44 Global IVD Market Share Analysis, By Key Player, 2017
Figure 45 Global Clinical Chemistry Market Share Analysis, By Key Players (2017)
Figure 46 Global Immunoassays Market Share Analysis, By Key Players (2017)
Figure 47 Global Microbiology Market Share Analysis, By Key Players (2017)
Figure 48 Global Molecular Diagnostics Market Share Analysis, By Key Players (2017)
Figure 49 Global Hematology Market Share Analysis, By Key Players (2017)
Figure 50 Global Clinical Coagulation Analyzers Market Share Analysis, By Key Players (2017)
Figure 51 F. Hoffmann-La Roche.: Company Snapshot (2016)
Figure 52 Danaher Corporation: Company Snapshot (2016)
Figure 53 Abbott Laboratories: Company Snapshot (2016)
Figure 54 Siemens AG: Company Snapshot (2017)
Figure 55 Sysmex Corporation: Company Snapshot (2017)
Figure 56 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 57 Becton, Dickinson and Company: Company Snapshot (2017)
Figure 58 Biomιrieux Sa: Company Snapshot (2016)
Figure 59 Bio-Rad Laboratories: Company Snapshot (2016)
Figure 60 Johnson & Johnson: Company Snapshot (2016)
Figure 61 Agilent Technologies: Company Snapshot (2016)
Figure 62 Qiagen: Company Snapshot (2016)
Figure 63 Diasorin: Company Snapshot (2016)

The global in vitro diagnostics market is projected to reach USD 87.93 Billion by 2023 from USD 68.12 Billion in 2018, at a CAGR of 5.2%. The rising demand for early and accurate disease diagnosis, increasing prevalence of infectious diseases, increasing adoption of fully-automated instruments and automation in laboratories, increasing adoption of point-of-care testing, and growing awareness of personalized medicine are the key factors driving the growth of the market.

This report broadly segments the market into product & service, technology, application, end user, and region.

On the basis of technology, the market is broadly divided into immunochemistry/immunoassay, clinical chemistry, molecular diagnostics, hematology, microbiology, coagulation & hemostasis, urinalysis, and other technologies. The immunochemistry/immunoassay segment is expected to dominate the market in 2018. The large share of this segment is primarily attributed to the growing preference for these technologies in clinical diagnostics over conventional methods and the ability of immunoassay/immunochemistry technologies to offer faster results with high-sensitivity and accuracy.

On the basis of end user, the market is segmented into laboratories, hospitals, academic institutes, point-of-care testing, patient self-testing, and other end users. The hospitals segment accounted for the largest share of the IVD market in 2017, owing to the large volume of diagnostic tests carried out in hospitals. However, the point-of-care testing segment is estimated to grow at the highest CAGR during the forecast period.

North America is expected to command the largest share of the market in 2018 owing to the availability of government funds, growing use of molecular diagnostics in genetic disorders and cancer screening, and the presence of key players in the region. However, Asia Pacific is expected to register the highest growth rate during the forecast period due to rising healthcare expenditure; increasing number of hospitals and clinical diagnostic laboratories in India and China; increasing incidence of chronic and infectious diseases; rapid development in the healthcare infrastructure of developing countries such as India, China, and South Korea; and increasing per capita income of the middle-class population in the region.

In Vitro Diagnostics/IVD Market

The major factors driving the growth of this market in the North American region include accessibility to advanced technologies, increasing demand for laboratory automation, expansion of molecular diagnostics for genetic disorders and cancer screening, and presence of major leading companies in the US.

The North American and European IVD markets are very developed due to the established healthcare systems in developed countries. As a result, there are heavy regulations on new and existing products and techniques which may restrain the market growth upto certain extent.

The prominent players in the global in vitro diagnostics market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMιrieux (France), DiaSorin (Italy), Ortho Clinical Diagnostics (US), Agilent Technologies (US), and QIAGEN (Germany)

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo